MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$656.87
−1.00%Margins
Gross margin
29.1%
EBITDA margin
22.7%
EBIT margin
21.4%
Net margin
18.2%
FCF margin
23.5%
88.5%
Return on equity
22.5%
Return on assets
83.1%
Return on invested capital
1.30x
Asset turnover
$723.0M
Cash from operations
$25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026